GlaxoSmithKline Pharmaceuticals Limited
GLAXO
Rangering i aksjer
#3775
GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise,... GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise, engages in the research, development, production, and global distribution of pharmaceutical drugs and vaccines. Its extensive product range encompasses both prescription and over-the-counter medications addressing diverse therapeutic areas such as anti-infectives, respiratory ailments, dermatology, nutritional deficiencies, gastrointestinal issues, and rare conditions. The company additionally provides consumer healthcare solutions. Prominent brands within its portfolio include Augmentin, Calpol, Ceftum, Eltroxin, Neosporin, Betnovate, Infanrix Hexa, Synflorix, and Boostrix, among numerous others. Founded in 1924 and headquartered in Mumbai, India, the company adopted its current name in 2001, having previously operated as SmithKline Beecham Pharmaceuticals India Ltd.
Aksjekurs
$25.73
Markedsverdi
$4.36B
Endring (1 dag)
-5.33%
Endring (1 år)
-17.92%
Land
IN
Handel GlaxoSmithKline Pharmaceuticals Limited (GLAXO)
Kategori
Healthcare
Aksjeprishistorikk for GlaxoSmithKline Pharmaceuticals Limited (GLAXO)
Høyeste sluttskurs: $28.33 den 2026-10-01
Laveste sluttskurs: $7.46 den 1999-01-01
Laveste sluttskurs: $7.46 den 1999-01-01
Aksjeprishistorikk for GlaxoSmithKline Pharmaceuticals Limited fra 1999 til 2026
Årlig aksjeprisytelse
| År | Ytelse |
|---|---|
| 2026 (TTM) | -0.80% |
| 2025 | 3.53% |
| 2024 | 30.13% |
| 2023 | 28.84% |
| 2022 | -31.26% |
| 2021 | 11.05% |
| 2020 | -8.11% |
| 2019 | 15.01% |
| 2018 | 5.68% |
| 2017 | -5.61% |
| 2016 | -18.58% |
| 2015 | 0.11% |
| 2014 | 11.37% |
| 2013 | 16.93% |
| 2012 | 5.11% |
| 2011 | -25.99% |
| 2010 | 39.42% |
| 2009 | 47.96% |
| 2008 | -8.92% |
| 2007 | -0.02% |
| 2006 | 7.37% |
| 2005 | 41.03% |
| 2004 | 38.71% |
| 2003 | 85.99% |
| 2002 | 3.08% |
| 2001 | -33.62% |
| 2000 | -42.61% |
| 1999 | 0.00% |
Aksjepris for lignende selskaper eller konkurrenter
| Selskap | Aksjepris | Endring 1år% | Land |
|---|---|---|---|
| $1.31K | 61.37% |
US
|
|
| $268.68 | 39.25% |
US
|
|
| $285.11 | 24.67% |
US
|
|
| $149.12 | 70.20% |
US
|
|
| $482.01 | 30.76% |
CH
|
